Summary:
When it comes to pharmaceuticals, you have heard the list of complaints. Drug prices are too high. Drug prices are not transparent. My insurance plan won’t cover X medication. Perhaps the complaint which should be raised but isn’t relates to China. Author Rosemary Gibson has rung a fire bell in the night with her book, China Rx: Exposing the Risks of America’s Dependence on China for Medicine.
When it comes to pharmaceuticals, you have heard the list of complaints. Drug prices are too high. Drug prices are not transparent. My insurance plan won’t cover X medication.
Perhaps the complaint which should be raised but isn’t relates to China. Author Rosemary Gibson has rung a fire bell in the night with her book, China Rx: Exposing the Risks of America’s Dependence on China for Medicine.
Well over 90% of the active ingredients of antibiotics in the U.S. are manufactured abroad. The vast majority of them are produced in China. Learn about the national security threats and quality oversight issues involved with the outsourcing of pharma manufacturing. This important episode will shock you.
Rosemary Gibson serves as Senior Advisor at The Hastings Center and a Section Editor for “Less is More,” in JAMA Internal Medicine. Ms. Gibson is an award-winning author, inspirational speaker, and advisor to organizations that advance the public’s interest in health care.www.rosemarygibson.org
China Rx: Exposing the Risks of America’s Dependence on China for Medicinehttps://www.amazon.com/ChinaRx
Topics
Environmental Influences
Healthcare Process
Economics
Related
From Volatility to Value: How Healthcare Leaders Can Fortify Supply Chain Strategy in 2026How Can I Increase Patient Loyalty in My Practice?The Collaboration Imperative: Why Healthcare Executives Must Unite Against an Existential ThreatRecommended Reading
Quality and Risk
From Volatility to Value: How Healthcare Leaders Can Fortify Supply Chain Strategy in 2026
Quality and Risk
How Can I Increase Patient Loyalty in My Practice?
Finance
The Collaboration Imperative: Why Healthcare Executives Must Unite Against an Existential Threat
Strategy and Innovation
From Clinician To C-Suite: When Expertise Isn’t Enough — Addressing Systemic Barriers to Physician Leader Success
Strategy and Innovation
The World Wants Physician Leaders and It Needs Leadership Development Opportunities